Investor profile
Rosetta Capital has backed 2 European tech companies across 2 funding rounds between 2014 and 2025, joining rounds totalling €60M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| NovImmune | Switzerland | 1 | €49M |
| MISSION Therapeutics | UK | 1 | €11M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| NovImmune | Series D+ | €49M | 2014-02 |
| MISSION Therapeutics | Other | €11M | 2025-10 |
